Introduction
============

Immortality is a common characteristic of cancers.[@R1]^-^[@R5] But it is still unclear how immortal cancers originate from mortal somatic cells[@R2]^-^[@R15] and why cancers are immortal, although normal somatic cells can grow into organs and organisms which contain many more cells than fatal cancers.[@R5]^,^[@R6] Immortality is operationally defined by growth in excess of the Hayflick limit, which is about 50 generations in vitro.[@R5]^,^[@R16]^,^[@R17]

To answer these questions, one would need to know: (1) How cancers are generated from somatic cells, which is also still a matter of debate;[@R5]^,^[@R8]^,^[@R9]^,^[@R11]^-^[@R13]^,^[@R18]^,^[@R19] (2) How cancer cells grow perpetually, despite the inevitable accumulation of spontaneous mutations of genes and chromosomes, termed "Muller's ratchet."[@R13]^,^[@R20]^-^[@R26] According to the geneticist Herman Muller, asexual species, such as cancers,[@R11]^-^[@R13] are doomed by extinction unless they have a mechanism to escape the ratchet; and (3) Why cancers are immortal, although immortality "cannot provide an immediate replicative advantage. Unless a cell can tell the future."[@R6]

The currently prevailing immortality theory postulates that cells are immortalized by activation of telomerase.[@R5]^,^[@R7]^,^[@R27]^-^[@R32] Since this enzyme is developmentally switched off in somatic cells, cancers are said to derive immortality from activation of telomerase. According to this theory, "Cells that have stabilized their telomeres through the actions of telomerase or the ALT mechanism proliferate indefinitely and are therefore said to be immortalized. Cell immortalization is a step that appears to govern the development of all human cancers."[@R5]

But, even telomerase genes that are artificially overexpressed by a cytomegalovirus- and a retrovirus-derived promoter[@R29]^,^[@R32]^-^[@R34] are not sufficient, and not even necessary to immortalize cells for the following reasons: mass cultures of "polyclonally"[@R29]^,^[@R34] transfected cells are karyotypically unstable and thus not immortal for many, up to over 100 unstable, generations before they become immortal[@R17]^,^[@R29]^,^[@R31]^,^[@R32]^,^[@R34]^-^[@R43] (see also Results below). Only \< 1 in 10^5^ cells of mass cultures transfected with artificially overexpressed telomerase genes (linked also to drug-resistance indicator genes) become clones of immortal cells.[@R17]^,^[@R34]^,^[@R42]^,^[@R44]^,^[@R45] Studying carcinogenesis in telomerase-deficient mice with transgenic oncogenes, Argilla et al. found that, "Absence of telomerase had minimal impact on tumorigenesis...telomere numbers and relative lengths were maintained during progression, implicating a means for preserving telomere repeats and functionality in the absence of telomerase." A search for these means, "revealed aneuploidy similar to that observed in human tumors."[@R46] It would thus appear that aneuploidy, rather than overexpressed telomerase, is necessary for immortalization.

Moreover, the telomerase theory does not explain how immortal cancers avoid the inevitably fatal consequences of accumulating spontaneous mutations over time in the non-telomeric sequences of their DNA, i.e., how they escape Muller's ratchet.[@R13]^,^[@R22]^-^[@R26]

In view of these discrepancies with the hypothetical immortalizing function of telomerase, immortalization has been postulated to depend on "additional mutational events," like the acquisition of an "oncogene,"[@R29]^,^[@R30] undefined "rare events,"[@R47]^,^[@R48]"recombination" with unidentified telomere sources,[@R49] "inactivation of tumor suppressors,"[@R39] an "ALT-2" mechanism"[@R46] and "genomic instability."[@R42] Since there are no consistent answers to these questions, we searched for an alternative theory of immortality.

Karyotypic theory of immortality
--------------------------------

Here we advance a new karyotypic theory of immortality, which is based on the theory that carcinogenesis is a form of speciation.[@R10]^-^[@R13]^,^[@R45] The speciation theory holds that cancers are generated by random rearrangements of the karyotypes of normal cells and selection for cancer-specific reproductive autonomy. Since such rearrangements unbalance long-established mitosis genes, cancer karyotypes vary spontaneously but are stabilized perpetually by clonal selections for autonomy. Immortality of cancers is thus a direct consequence of a dynamic equilibrium between spontaneous karyotypic variation and selection for reproductive autonomy---as it is in principle also for sexual species, although at a much lower rate.[@R50]^-^[@R55] This dynamic equilibrium between variation and selection for autonomy also explains the constitutive heterogeneity of cancer karyotypes.[@R56]^-^[@R58] The theory thus predicts that autonomous clonal but flexible karyotypes generate immortality.

To test this theory, we asked whether immortality of human cell lines, currently attributed to transfection with overexpressed telomerase, correlates with clonal flexible karyotypes, and whether immortality originates simultaneously with such karyotypes. Further we asked, whether in the absence of telomerase, SV40 tumor virus induces immortal neoplastic clones with flexible karyotypes in cells of a telomerase-deficient mouse.

Results
=======

Immortal tumorigenic clones derived from human cells transfected with overexpressed telomerase have clonal flexible karyotypes
------------------------------------------------------------------------------------------------------------------------------

As a first test of the theory that karyotypic flexibility immortalizes we asked, whether flexible clonal karyotypes are present in three known immortal tumorigenic cell lines named HA1, HA1-2 and BJ.[@R29] These lines arose from mass cultures of primary human kidney (HA1 and HA1-2) and skin cells (BJ), "approximately 60 population doublings" after transfection with artificially overexpressed telomerase and two artificially overexpressed oncogenes.[@R29]

Because of these long latent periods we have questioned in the past whether the transfected genes were sufficient for tumorigenicity and immortalization. In a first effort to find an alternative explanation, we looked for cancer-specific aneuploidy, and found that all three of these cell lines were highly aneuploid.[@R59]^,^[@R60] An initial karyotype of HA1, prepared here as described in "Materials and Methods," confirmed our earlier findings of aneuploidy ([Fig. 1](#F1){ref-type="fig"}).

![**Figure 1.** Karyotype of the immortal tumorigenic HA1 cell line, which originated late after transfection of human kidney cells with overexpressed telomerase. The chromosomes were prepared from metaphases and labeled by hybridization with chromosome-specific colors as described in "Materials and Methods."](cc-12-783-g1){#F1}

In view of this and our new karyotypic immortality theory, we ask now whether the three cell lines contain the clonal and flexible karyotypes predicted by this theory. For this purpose we used 3-dimensional arrays of 20 karyotypes---a technique, which we had recently developed to detect clonality within the karyotypic heterogeneity of cancers.[@R11]^,^[@R45]^,^[@R61] Such karyotype arrays list chromosome numbers on the x-axis, chromosome copy numbers on the y-axis and the number of metaphases arrayed on the z-axis.

The karyotype arrays of HA1, HA1--2 and BJ, shown in [Figure 2](#F2){ref-type="fig"} and [Table 1](#T1){ref-type="table"}, clearly indicate that all three cell lines were clonal: the chromosome numbers of HA1 were 82 ± 1, those of HA1-2 were 47 ± 4, and those of BJ were 82 ± 5, and thus highly clonal. Moreover, the copy numbers of the individual chromosomes of HA1 were 85 to 100% clonal, those of HA1-2 were 85 to 90% clonal, and those BJ were 75 to 100% clonal. As a result of this high clonality, the copy numbers of most chromosomes of the three lines formed parallel lines in the arrays shown [Figure 2](#F2){ref-type="fig"}. By contrast, a minority of chromosome numbers differed from the clonal values within narrow margins of ± 1 and thus stood out above or below the patterns formed by the parallel lines. The relative clonality and non-clonality can thus be seen in each array at a glance. In sum, all three cell lines contained the clonal and flexible karyotypes predicted by our theory.

![**Figure 2.** Three-dimensional arrays of 20 karyotypes of the immortal tumorigenic human cell lines HA1 and HA1-2 and BJ based on the cytogenetic data listed in [Table 1](#T1){ref-type="table"}. HA1 and HA1-2 lines originated late from human kidney cells ([Fig. 1](#F1){ref-type="fig"}), and BJ from human skin cells about 60 generations after transfection of mass cultures with artificially overexpressed telomerase and two overexpressed oncogenes (text). The karyotype arrays are three-dimensional tables, which show the chromosome numbers of 20 karyotypes on the x-axis, the copy numbers of each chromosome on the y-axis and the number of karyotypes arrayed on the z-axis. By forming parallel lines, the chromosome copy numbers of 20 karyotypes indicate that the three lines are highly clonal. A minority of non-clonal copy numbers differing from the clonal values in narrow margins of ± 1, stands out above or below these lines ([Table 1](#T1){ref-type="table"}). This indicates that all three lines have clonal but flexible karyotypes.](cc-12-783-g2){#F2}

###### **Table 1.** Chromosome numbers and copy numbers of immortal, tumorigenic clones HA1, HA1--2 and BJ

  Neoplastic clones   HA1      HA1--2   BJ
  ------------------- -------- -------- --------
  1                   3(50)    2(90)    2(85)
  2                   3(80)    2(90)    3(75)
  3                   4(95)    2(90)    3(90)
  4                   3(100)   2(90)    3(90)
  5                   4(95)    2(95)    3(95)
  6                   4(95)    2(90)    4(80)
  7                   3(85)    2(90)    2(85)
  8                   4(85)    2(85)    3(95)
  9                   4(100)   2(85)    3(90)
  10                  4(95)    2(95)    4(95)
  11                  3(95)    2(80)    3(95)
  12                  4(90)    2(85)    3(80)
  13                  2(90)    2(85)    4(75)
  14                  3(95)    2(85)    4(85)
  15                  4(85)    2(95)    4(90)
  16                  4(90)    2(90)    3(80)
  17                  3(90)    2(95)    3(85)
  18                  1(85)    2(90)    3(90)
  19                  3(100)   2(95)    2(90)
  20                  4(90)    1(95)    4(95)
  21                  3(95)    2(90)    3(100)
  22                  4(90)    2(90)    3(90)
  X                   2(100)   1(95)    2(95)
  Y                   1(100)   1(15)    2(95)
  der(17;19)          1(100)   \-       \-
  der(1;19)           1(90)    \-       \-
  min(18)             1(80)    \-       \-
  der(18)             1(95)    \-       \-
  min(8)              0(60)    \-       \-
  der(1)              1(10)    \-       \-
  der(20;13)          \-       1(95)    \-
  der(3;17)           \-       \-       1(50)
  der(16;12)          \-       \-       1(65)
  der(17;22)          \-       \-       1(100)
  der(11;19)          \-       \-       1(80)
  der(1;3)            \-       \-       1(90)
  der(X;2)            \-       \-       1(95)
  der(4;8)            \-       \-       1(100)
  der(5;2?;8)         \-       \-       1(90)
  der(9;19)           \-       \-       1(100)
  der(11;7)           \-       \-       1(95)
  der(1;18)           \-       \-       1(80)

Further studies from other researchers including us have confirmed that other immortal tumorigenic lines derived from mass cultures of human cells transfected with artificially overexpressed telomerase, and various oncogenes also contain clonal and flexible karyotypes and also had evolved only late after transfection with overexpressed telomerase and additional oncogenes.[@R42]^,^[@R45]^,^[@R61]^,^[@R62]

### Conclusions

\(1\) Based on exact correlations between tumorigenicity and immortality and clonal but flexible karyotypes in all neoplastic clones derived from cells transfected with overexpressed telomerase, we conclude that such karyotypes are necessary, perhaps even sufficient, for immortality.

\(2\) Based on the clonality of the three tumorigenic and immortal clones and the long pre-neoplastic and pre-immortal latencies of 60 generations from transfection with overexpressed genes, we conclude that tumorigenesis and immortalization are extremely rare and possibly simultaneous clonal events. It follows that overexpressed telomerase and overexpressed oncogenes are not sufficient for immortalization and transformation.

In the following we ask how overexpressed telomerase induces immortal tumorigenic clones, and whether it plays a lasting role in their immortality.

How does overexpressed telomerase induce immortal tumorigenic clones?
---------------------------------------------------------------------

The speciation theory predicts that carcinogenesis is initiated by random aneuploidy[@R10]^-^[@R13]^,^[@R45] (Introduction). According to this theory, biological carcinogens like oncogenic viruses and artificially overexpressed cellular genes or non-biological chemical and physical carcinogens, or spontaneous events induce this random aneuploidy.[@R11]^,^[@R45]^,^[@R47]^,^[@R48]^,^[@R61]^-^[@R68] Since aneuploidy unbalances long-established mitosis genes, it self-catalyzes progressions of aneuploidy toward two ends: (1) lethal karyotypes that perish; and (2) new autonomous cancer karyotypes that are stabilized by clonal selection for cancer-specific reproductive autonomy[@R11]^,^[@R45] (Introduction). Aneuploidy would thus be the proximal carcinogen. Because the probability of generating a new autonomous cancer or other species by random karyotypic rearrangements is very low, the latent periods from initiating aneuploidy to the origin of a new immortal species are very long and the resulting species are clonal, just as it was with the three cell lines described above.

To test the predicted role of random aneuploidy in the generation of an immortal neoplastic clone, we karyotyped human skin fibroblasts that had been immortalized by transfection with overexpressed telomerase by Mondello et al. in Pavia, Italy.[@R32]^,^[@R40] Mondello et al. have studied the time course of immortalization of skin fibroblasts from a centenarian woman from transfection with overexpressed telomerase to over 1,000 generations or population doublings (PD) in vitro.[@R32]^,^[@R40] We were particularly interested in this system, because Mondello et al. had already observed aneuploidy before and after immortalization.[@R32]^,^[@R40]

### Transfection with overexpressed telomerase induces random aneuploidy prior to immortalization

In agreement with Mondello et al.,[@R32]^,^[@R40] we found that after transfection with overexpressed telomerase, the skin cells from a centenarian woman, hence cen3tel, evolved as follows: 37 generations after transfection, at PD37, the cells had a typical fibroblastic, fusiform phenotype ([Fig. 3A](#F3){ref-type="fig"}). Sixty-three generations later, at PD100, the cen3tel cells still had a basic fibroblastic phenotype. However, during that time, the cells had become less fusiform, had acquired a 2--3-fold higher growth rate and grew to a higher density per culture dish than their PD37 precursors (compare [Fig. 3A and B](#F3){ref-type="fig"}).

![**Figure 3.** Cellular phenotypes of human cen3tel skin cells from a centenarian female 37 (**A**), 100 (**B**), 166 (**C**) and 1014 (**D**) generations after transfection with overexpressed telomerase. The culture had a fibroblastic cellular phenotype at PD37 (**A**) and a less defined fibroblastic phenotype at generation PD100 (**B**). At generation PD166, the culture had acquired a polymorphic cellular phenotype typical of cancer cells and simultaneously became tumorigenic and immortal (**C**). This new polymorphic phenotype was unchanged at PD1014 (**D**).](cc-12-783-g3){#F3}

The karyotypic analyses of the cen3tel culture at PD37 and PD100 show, in [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}, that the culture was 60% aneuploid at 37 generations, and was 100% aneuploid at 100 generations after transfection with overexpressed telomerase. Further, while the chromosome copy numbers of aneuploid cells at PD37 were near-diploid, the chromosome copy numbers at PD100 ranged from 1 to 4 and beyond. Thus cen3tel at PD100 differed from PD37 not only in the percentage, but also in the degree of aneuploidy.

###### **Table 2.** Karyotypes of 20 cen3tel cells 37 generations after transfection with overexpressed telomerase

  Metaphases   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20
  ------------ --- --- --- --- --- --- --- --- --- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  1            2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    2    3
  2            2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    2    3
  3            2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    2    3
  4            2   2   2   2   2   2   2   2   2   2    2    2    2    2    1    3    2    2    2    2
  5            2   2   2   2   2   2   2   2   2   2    1    1    1    1    2    2    2    2    1    2
  6            2   2   2   2   2   2   2   2   2   2    2    1    1    1    2    2    2    2    2    4
  7            3   3   3   3   3   3   3   3   3   3    3    3    3    3    3    2    2    2    2    5
  8            2   2   2   2   2   2   2   2   2   2    1    2    2    2    2    1    2    2    0    1
  9            2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    1    2
  10           2   2   2   2   2   2   2   2   2   2    2    2    2    1    2    2    2    2    0    4
  11           2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    2    4
  12           2   2   2   2   2   2   2   2   2   3    2    2    2    2    2    3    2    2    0    3
  13           2   2   2   2   2   2   2   2   2   1    2    2    2    1    2    2    2    2    0    2
  14           2   2   2   2   2   2   2   2   1   2    1    2    2    2    2    2    2    1    1    3
  15           2   2   2   2   2   2   2   2   1   2    2    2    2    2    2    2    2    2    2    3
  16           2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    0    1
  17           2   2   2   2   2   2   2   2   1   2    2    2    1    2    2    2    2    2    0    4
  18           2   2   2   2   2   2   2   2   2   1    2    2    2    2    2    2    2    2    0    1
  19           2   2   2   2   2   2   2   2   2   2    2    0    2    2    2    2    2    2    2    4
  20           2   2   2   2   2   2   2   2   2   2    2    1    2    2    1    2    2    2    1    2
  21           2   2   2   2   2   2   2   2   2   1    2    2    2    2    2    2    2    2    1    3
  22           2   2   2   2   2   2   2   2   2   2    2    2    2    2    1    1    2    2    2    4
  X            2   2   2   2   2   2   2   2   2   2    2    2    2    2    2    2    2    2    2    2
  Y            0   0   0   0   0   0   0   0   0   0    0    0    0    0    0    0    0    0    0    0
  t(6;10)      0   0   0   0   0   0   0   0   0   0    0    0    0    1    0    0    0    0    0    0

###### **Table 3.** Karyotypes of 20 cen3tel cells 100 generations after transfection with overexpressed telomerase

  Metaphase     1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20
  ------------- --- --- --- --- --- --- --- --- --- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  1             2   2   2   2   2   2   2   4   3   4    4    2    2    3    3    4    4    4    4    4
  2             1   1   1   1   1   2   2   3   3   2    3    2    2    2    4    0    2    2    3    3
  3             2   2   2   2   2   2   7   4   4   3    3    2    2    3    2    2    3    7    4    4
  4             2   2   2   2   2   2   1   2   3   4    4    1    2    2    1    1    2    2    1    3
  5             1   2   2   2   2   2   3   4   4   3    4    2    2    3    4    2    3    3    4    4
  6             2   2   2   2   2   2   4   3   3   3    3    2    2    2    2    2    3    4    2    3
  7             3   3   3   3   3   3   3   3   6   6    6    2    1    2    2    2    2    2    2    5
  8             2   2   2   2   2   2   2   4   4   4    4    2    2    4    3    2    3    4    3    4
  9             2   1   2   2   2   1   4   3   4   4    3    2    2    2    2    2    3    4    2    3
  10            1   2   2   2   2   2   1   2   2   4    3    2    1    1    2    2    2    1    2    3
  11            2   2   2   2   2   2   3   2   4   3    4    1    2    2    2    0    2    2    1    4
  12            2   2   2   2   2   2   2   4   4   4    4    2    2    3    3    2    4    3    4    4
  13            2   1   1   2   2   2   3   2   2   2    2    2    2    1    2    2    2    2    1    2
  14            2   2   2   2   2   3   4   3   2   3    2    2    3    3    2    1    2    3    2    2
  15            2   2   2   2   2   2   2   4   2   3    1    3    2    3    3    1    2    3    3    2
  16            2   1   2   2   2   2   4   2   4   4    4    2    2    2    3    2    3    2    4    4
  17            2   2   2   1   2   2   0   3   4   2    2    1    2    2    2    1    2    1    3    2
  18            1   2   2   2   2   2   5   3   4   3    3    2    2    4    3    2    4    2    3    4
  19            2   2   2   2   2   2   5   4   4   4    4    2    2    4    3    4    2    2    2    4
  20            2   2   2   2   2   2   8   4   4   4    4    1    2    4    4    3    4    1    1    4
  21            4   3   3   2   3   3   3   4   3   4    4    1    3    3    3    2    2    1    2    4
  22            2   2   2   2   2   2   5   4   4   3    3    1    2    4    3    4    3    1    3    3
  X             2   2   2   2   2   2   3   4   3   4    4    2    2    3    3    1    3    4    4    2
  Y             0   0   0   0   0   0   0   0   0   0    0    0    0    0    0    0    0    0    0    0
  der(14q;2)    1   1   0   1   1   0   0   0   0   1    0    0    0    0    0    0    0    0    1    0
  der(17)       0   0   0   1   0   0   0   1   0   2    2    1    0    2    0    1    2    0    0    2
  der(14p;2)    1   1   1   0   1   0   0   0   0   0    0    0    0    0    0    0    0    0    0    0
  der(11:21)    0   0   0   0   0   0   0   0   0   0    0    1    0    2    1    0    1    0    1    0
  der(21)       0   0   0   1   0   0   1   0   2   2    2    0    0    0    0    0    1    0    0    2
  der(10)       0   0   0   0   0   0   0   2   2   0    0    0    0    0    1    0    2    1    2    0
  der(11)       0   0   0   0   0   0   0   3   0   0    0    1    0    1    0    0    2    0    1    0
  der(2;X)      0   0   0   0   0   0   0   0   1   0    0    0    0    0    0    0    0    0    0    1
  der(2:6)      0   0   0   0   0   0   0   0   0   1    1    0    0    0    0    0    0    0    0    0
  der(21;2)     0   0   0   0   0   0   2   0   0   0    0    0    0    0    0    2    0    0    0    0
  der(8;14;2)   0   0   1   1   0   0   0   0   0   0    0    0    0    0    0    0    0    0    0    0
  der(5;10)     0   0   0   0   0   0   2   0   0   0    0    0    0    0    0    1    0    0    0    0

  Non-clonal Markers                                                                                
  -------------------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  der(2;21)                                    1                                   1                
  der(9:11)                                1                                                        
  der(21;1)                                            1                                            
  der(7)                                                                                           1
  der(22:6)                                                                                    1    
  der(18:19)                                               1                                        
  der(5;22)                                                1                                        
  der(11;12)                                                                               2        
  der(6:9)                                                                                 1        
  der(10;21)                                                                       1                
  der(17:1)                                                                        1                
  der(1;17)                                    2                                                    
  der(6;9)                                     2                                                    
  der(12;16)                                   2                                                    
  der(10;21)                                   1                                                    
  der(1;17) short                              1                                                    
  der(4;7;22)                                                      1                                
  der(3;18)                                                    1                                    
  der(9;18)                                                    1                                    
  der(1)                                               1                                            
  der(2;14;2)                                                                      1                
  der(16)                  1                                                                        

![**Figure 4.** Aneuploidy among karyotypes of 20 human cen3tel skin cells 37 (**A**) and 100 (**B**) generations after transfection with overexpressed telomerase. The 20 karyotypes were arrayed as described for [Figure 2](#F2){ref-type="fig"}. The data show that 60% of the cen3tel cells were randomly aneuploid 37 generations after transfection ([Table 2](#T2){ref-type="table"}), and that 100% were randomly aneuploid 100 generations after transfection ([Table 3](#T3){ref-type="table"}). Moreover, the data show that the degree of aneuploidy increased sharply from generation 37 to generation 100 after transfection. The partial clonality of trisomy 7 was native of the cen3-skin biopsy studied here (see text).](cc-12-783-g4){#F4}

Moreover, some aneusomies had reached low degrees of clonality during the progression of aneuploidy from PD37 to PD100. For example, 12 new marker chromosomes of PD100 were shared subclonally by 2--9 of 20 karyotypes, and one new monosomy 2 was shared by five karyotypes ([Table 3](#T3){ref-type="table"}). At the same time, 15 of 20 cen3tel cells at PD37 had retained a trisomy 7 that was subclonal in the original cen3 biopsy[@R32] ([Table 2](#T2){ref-type="table"} and [Fig. 4A](#F4){ref-type="fig"}). This trisomy 7 was still present in 8 of 20 cen3tel cells at PD100 and in 3 of 20 PD100-cells in the form of a hexasomy 7 ([Fig. 4B](#F4){ref-type="fig"}). Such subclonalities indicate that some randomly generated aneuploidies provide growth advantages.

The spontaneous increases in the percentages and the degrees of aneuploidies, and the evolution of subclonal aneuploidies of the cen3tel culture from PD37 to PD100 thus support the prediction of the speciation theory that aneuploidy progresses automatically based on newly generated growth advantages.

These results also confirm and extend earlier studies of Heng et al.[@R69] showing that aneuploidies confer growth advantages to somatic cells from humans with genetic instability, and studies of Berman and Pavelka et al.[@R15]^,^[@R70]^,^[@R71] showing that certain aneuploidies confer growth advantages to various strains of yeast. It seems probable, therefore, that such aneuploidy-specific growth advantages might also explain the pre-neoplastic human hyperplasias detected in vivo ever since Papanicolaou.[@R72]^,^[@R73]

#### Conclusions

\(1\) Overexpressed telomerase is not sufficient for immortalization, because the transfected cells have highly unstable, aneuploid karyotypes.

\(2\) Transfection of human cells with overexpressed telomerase induces random aneuploidies, which offer growth advantages. As a result of these advantages, the aneuploidies progress spontaneously and even form subclonal subsets. These aneuploidy-generated growth advantages thus explain the 2--3-fold increases in the growth rates of cen3tel cells following transfection with overexpressed telomerase.

### New tumorigenic clone evolves late from randomly aneuploid cells

During the 66 cell generations from PD100 to PD166, the cen3tel culture acquired the neoplastic abilities to grow in agar gels and to form tumors in immunodeficient athymic mice.[@R32]^,^[@R40] At the same time the cellular phenotype of the cen3tel cells changed completely from fibroblastic spindle-shaped to cubic-polymorphic, which is characteristic of cancer cells ([Fig. 3A--C](#F3){ref-type="fig"}). Moreover the cen3tel cells at PD166 grew 3-dimensionally, which is also characteristic of cancer cells.[@R74]

To determine whether this cancer-specific phenotypic transformation coincided with the evolution of a new clonal and flexible cancer karyotype, we prepared an array of 20 cen3tel PD166 karyotypes, which is shown in [Figure 5A](#F5){ref-type="fig"} and [Table 4](#T4){ref-type="table"}. It can be seen in [Table 4](#T4){ref-type="table"} that the chromosome numbers of the tumorigenic cen3tel PD166 clone were 76 ± 3, and thus were highly clonal. The table also shows that the 76 clonal chromosomes included 14 new PD166-specific marker chromosomes. Further the array shows that the copy numbers of most chromosomes of the 20 karyotypes were clonal, forming parallel lines, which are characteristic of clonality (see above "Results," "Immortal tumorigenic clones..."). At the same time a minority of chromosomes were non-clonal, forming non-parallel points within narrow ± 1 margins of variation above and below these parallel lines. The non-clonal copy numbers were thus near-clonal. The percentages of clonal vs. near-clonal chromosome copy numbers ranged from 60 to 100% ([Table 4](#T4){ref-type="table"}).

![**Figure 5.** Karyotypic stability and drift of the tumorigenic clone cen3tel PD166 at the time of isolation (**A**) and after 451 (**B**) and 848 (**C**) unselected generations in vitro. As a test for immortalization, karyotype arrays prepared from the original clone cen3tel PD166 and descendents isolated 451 (PD617) and 848 (PD1014) unselected generations later were compared. These karyotype arrays show that the original cen3tel PD166 karyotype was mostly stable, but was also variable within narrow margins over 848 cell generations ([Table 4](#T4){ref-type="table"}). The copy numbers of 21 of 33 (64%) PD166-specific chromosomes including marker chromosomes were clone-specific during 848 generations, while 12 of 33 (36%) were generation-specific or cell-specific drifting within narrow margins of ± 1 over 848 generations ([Table 4](#T4){ref-type="table"} and [Fig. 6](#F6){ref-type="fig"}). Based on the high clonal stability over 848 unselected generations, we conclude that the cen3tel PD166 clone is immortal but flexible, exceeding the operational Hayflick threshold of 50 generations by 798 clonal generations.](cc-12-783-g5){#F5}

###### **Table 4.** Chromosome numbers and copy numbers of the tumorigenic clone cen3tel PD166, and at subsequent generations PD617 and PD1014

  Cen3tel clones   PD166     PD617    PD1014
  ---------------- --------- -------- ---------
  1                2 (95)    2 (65)   1 (80)
  2                3 (70)    3 (76)   2 (60)
  3                1 (95)    1 (82)   1 (95)
  4                2 (95)    2 (65)   2 (100)
  5                3 (80)    2 (65)   2 (90)
  6                2 (95)    2 (59)   1 (75)
  7                2 (90)    3 (65)   3 (60)
  8                3 (80)    4 (71)   3 (60)
  9                3 (85)    1 (94)   1 (100)
  10               2 (70)    2 (88)   2 (85)
  11               4 (65)    3 (65)   3 (90)
  12               3 (80)    3 (71)   3 (80)
  13               2 (100)   2 (88)   2 (100)
  14               3 (95)    3 (82)   3 (100)
  15               2 (75)    2 (76)   2 (100)
  16               2 (65)    3 (53)   3 (60)
  17               3 (100)   3 (59)   3 (90)
  18               3 (65)    3 (71)   3 (75)
  19               4 (90)    3 (59)   3 (80)
  20               4 (95)    3 (53)   4 (65)
  21               2 (65)    2 (82)   2 (95)
  22               2 (80)    2 (82)   2 (85)
  X                4 (85)    3 (35)   3 (70)
  Y                0         0        0
  der(1;3)         1 (100)   1 (88)   1 (95)
  der(3;1)         1 (90)    1 (76)   1 (95)
  der(3;10)        1 (95)    1 (71)   1 (95)
  der(6;22)        1 (80)    1 (94)   1 (100)
  der(9p)          1 (100)   1 (76)   1 (95)
  der(4)           1(100)    1(82)    1 (100)
  der(10)          1 (85)    1 (65)   1 (95)
  der(7)           1 (80)    1 (65)   1 (75)
  der(1q)          1 (75)    1 (6)    1 (5)
  der(8q)          1 (45)    1 (12)   1 (50)
  i(5p)            1 (85)    1 (59)   \-
  der(6p)          1 (85)    \-       \-
  der(16;3)        1 (85)    \-       \-
  der(12;14)       1 (75)    \-       \-
  der(10;16)       1 (55)    \-       \-
  der(9q)          \-        1 (88)   1 (100)
  der(5;9)         \-        1 (82)   1 (100)
  der(15;1)        \-        1 (71)   1 (100)
  der(17;5)        \-        1 (71)   1 (35)
  der(6;3)         \-        1 (65)   1 (90)
  der(1;12)        \-        1 (6)    1 (55)
  der(8;5)         \-        1 (6)    1 (55)
  der(1;5)         \-        1 (6)    1 (55)
  der(1p;12)       \-        1 (76)   \-
  der(6)           \-        \-       1 (75)
  der(17;8)        \-        \-       1 (70)
  der(2)           \-        \-       1 (55)

Given the rough chronological time points available, we estimate that the stem cell of cen3tel PD166 originated at or before PD146 as follows. Since we maintained cultures of at least 1 million cells, and since it takes about 20 cell generations to multiply one cell to 1 million (10^6^ = 2^20^), we deduce that the stem cell of PD166 must have arisen at PD146, at least 20 generations before PD166. In the following 20 generations it would have supplanted all non-clonal aneuploid precursors by the new tumorigenic PD166 cells (see also "Discussion" and [Fig. 11](#F11){ref-type="fig"}).

![**Figure 11.** Karyotypic stages during carcinogenesis of a virtual organ of 10^6^ cells: (1) The induction of random aneuploidy in an arbitrary 1% of normal cells by a carcinogen, such as overexpressed telomerase ([Fig. 4](#F4){ref-type="fig"}) or SV40 virus ([Figs. 9](#F9){ref-type="fig"} and [10](#F10){ref-type="fig"}); (2) Self-catalyzed progression of aneuploidy over many cell generations up to 100% of the initiated cell population, as for example in the human skin cells 100 generations after aneuploidization by overexpressed telomerase shown in [Figure 4](#F4){ref-type="fig"}; (3) The stochastic evolution of an autonomous cancer stem cell with a new, clonal flexible karyotype and phenotype. The new autonomous cancer cell supplants the 10^6^ non-cancerous precursors in our Petri dish within 20 generations after its origin ([Figs. 5](#F5){ref-type="fig"} and [8](#F8){ref-type="fig"}); (4) Self-catalyzed karyotypic variations of cancer cells generate new unselected subspecies, spontaneously ([Figs. 5](#F5){ref-type="fig"}[and 8](#F8){ref-type="fig"}) and drug-resistant or metastatic subspecies, selectively (see text).](cc-12-783-g11){#F11}

#### Conclusions

\(1\) Since neither tumorigenicity, nor clonal and flexible karyotypes, nor non-fibroblastic, polymorphic cell phenotypes were observed in the preneoplastic cen3tel mass culture before PD166, it is hard to escape the conclusion that the new clonal and flexible PD166 karyotype generated the new tumorigenic cen3tel PD166 clone. The recent identification of a new, cen3tel PD166-specific transcriptome by Ostano et al. lends independent support to this conclusion. They found that none of about 15 (except perhaps 1) cen3tel PD166-specific transcripts were shared with the preneoplastic cen3tel precursors at PD37 and PD97.[@R75] It follows that the new PD166-transcriptome generates the new phenotypes of the cen3tel PD166 clone.

\(2\) The speciation theory also predicts the clonal heterogeneity of the neoplastic cen3tel PD166 clone, based on the underlying karyotypic flexibility of cancer karyotypes (Introduction).

\(3\) The random, preneoplastic aneuploidies of PD37 and PD100 followed by the new clonal, neoplastic karyotype of PD166 confirm the prediction of the speciation theory that aneuploidy is the proximate carcinogen.

In the following we ask whether the new tumorigenic cen3tel PD166 clone is indeed immortal, and, if so, whether it had acquired immortality together with tumorigenicity.

### During 848 unselected generations the clonal chromosome number of cen3tel PD166 is stable, but the copy numbers of 36% of chromosomes drift ± 1

To determine whether the new, tumorigenic cen3tel PD166 clone is immortal in terms of the Hayflick definition, we compared the karyotypes of cen3tel PD166 during 848 unselected generations from PD166, when it was first identified, to its late descendants at PD617 and at PD1014.

These comparisons indicate that the chromosome numbers of cen3tel PD166 were 76 ± 3 at PD166, 72 ± 4 at PD617 and 73 ± 1 at PD1014 and thus were highly clonal and stable over 848 generations ([Table 4](#T4){ref-type="table"}). The copy numbers of 21 of 33 (64%) PD166 chromosomes were clonally conserved over 848 generations, while 12 of 33 (36%) chromosome numbers drifted within narrow margins of ± 1 ([Table 4](#T4){ref-type="table"} and [Fig. 5A--C](#F5){ref-type="fig"}). In addition to this quantitative drift of chromosome copy numbers, cen3tel at PD617 also differed from its precursor PD166 in four new generation-specific clonal markers, and cen3tel PD1014 differed in 10 generation-specific clonal markers ([Table 4](#T4){ref-type="table"}).

In [Figure 6](#F6){ref-type="fig"} we show the karyotypic consequences of 848 generations of unselected drift on two randomly selected karyotypes of PD166 and of PD1014 side-by-side. It can be seen that the two karyotypes differed from each other in generation-specific and cell-specific (non-clonal) copy numbers ([Table 4](#T4){ref-type="table"}) and marker chromosomes ([Table 4](#T4){ref-type="table"}, also marked in [Fig. 6](#F6){ref-type="fig"}), which could only be distinguished as such with the statistics of the karyotype arrays.

![**Figure 6.** Two individual karyotypes of the cen3tel clone PD166 at its origin (**A**) and after 848 generations of unselected growth in culture at PD1014 (**B**). About 64% of the chromosomes of the two karyotypes share PD166-specific copy numbers or are common markers ([Table 4](#T4){ref-type="table"} and [Fig. 5](#F5){ref-type="fig"}). The two karyotypes differ in generation-specific and cell-specific chromosomal copy numbers and markers \[labeled in (**A and B**)\] that could only be distinguished as such by the statistical analyses of the karyotype arrays shown in [Figure 5](#F5){ref-type="fig"}.](cc-12-783-g6){#F6}

But, despite such variations, the basic karyotype of PD166 was stably clonal and flexible over 848 cell generations. In agreement with the stability of this karyotype, the new transformation-specific phenotype of PD166 was also stable during 848 generations ([Fig. 3C and D](#F3){ref-type="fig"}).

#### Conclusion

Based on its karyotypic and phenotypic stability over 848 generations, we conclude that cen3tel PD166 is immortal within clonal margins of variation. Indeed, the evidence for 848 generations of clonal stability and flexibility obtained here far exceeds the operational Hayflick threshold of immortality of 50 generations. This result confirms and extends the theory that the immortality of cancers is karyotypic.

Next, we asked whether tumorigenicity and immortality are also karyotypically united in independent tumorigenic clones, derived from the same primary cen3tel culture from which cen3tel PD166 was obtained.

An independent immortal and tumorigenic clone arises from preneoplastic cen3tel cells after an individual latency
-----------------------------------------------------------------------------------------------------------------

In the following we test the prediction of the speciation theory that tumorigenicity and immortality are karyotypically linked in all neoplastic clones. By contrast, the telomerase theory predicts immortalization to be an independent genetic event and thus not inevitably linked to tumorigenesis.[@R5]^,^[@R27]

To distinguish between these alternatives, we studied an independent tumorigenic clone that arose from an aliquot of the same preneoplastic cen3tel cells from which cen3tel PD166 originated. The aliquot was taken only "a few" cell generations after transfection (Mondello, unpublished). This aliquot was termed cen3telS2 and was maintained and tested for tumorigenicity and immortality exactly like the parental cen3tel culture.

About 84 cell generations after transfection, at PD84, the independently growing cen3telS2 mass culture had become tumorigenic. The individual karyotype of cen3telS2 PD84 indicated that the new clone was indeed independent of cen3tel PD166 ([Fig. 7A](#F7){ref-type="fig"}).

![**Figure 7.** (**A**) Karyotype of the immortal tumorigenic clone cen3telS2 PD84, which arose from an independent preneoplastic aliquot of the cen3tel mass culture 84 generations after it was transfected with overexpressed telomerase. (See above Results, "How does overexpressed telomerase induce...") (**B**) Karyotype of cen3telS2 PD143, which supplanted the PD84 clone 59 generations after it was identified at PD84.](cc-12-783-g7){#F7}

To determine whether the new tumorigenic cen3telS2 culture had a new clonal and flexible karyotype, an array of 20 individual karyotypes was prepared ([Table 5](#T5){ref-type="table"} and [Fig. 8](#F8){ref-type="fig"}). This array shows that PD84 has a highly clonal chromosome number of 46 ± 1, which included three clonal S2-specific marker chromosomes. The new karyotype was thus pseudo-diploid. The array also shows that the chromosome copy numbers of the cen3telS2 PD84 culture were 75--90% clonal, except for three non-clonal marker chromosomes ([Fig. 8A](#F8){ref-type="fig"} and [Table 5](#T5){ref-type="table"}). The presence of some non-clonal chromosomes is, of course, expected from the inherent flexibility of neoplastic karyotypes. Thus, cen3telS2 PD84 is a new clone with an individual, clonal and flexible karyotype that independently originated from the preneoplastic cen3tel mass culture described above.

###### **Table 5.** Chromosome numbers and copy numbers of immortal, tumorigenic clones cen3telS2 PD84 and subclone cen3telS2 PD143

  Cen3telS2 clones   PD84    PD143
  ------------------ ------- --------
  1                  2(85)   4(100)
  2                  2(75)   4(90)
  3                  2(85)   4(95)
  4                  1(80)   2(100)
  5                  2(85)   4(100)
  6                  2(85)   4(95)
  7                  2(85)   6(90)
  8                  2(80)   2(80)
  9                  2(85)   4(85)
  10                 1(90)   3(95)
  11                 2(75)   4(95)
  12                 2(85)   4(100)
  13                 2(75)   2(100)
  14                 2(75)   3(95)
  15                 1(85)   3(100)
  16                 2(90)   4(95)
  17                 1(90)   2(90)
  18                 2(75)   4(95)
  19                 2(85)   4(80)
  20                 2(80)   4(95)
  21                 2(85)   2(85)
  22                 2(85)   2(95)
  X                  2(80)   3(95)
  Y                  0       0
  der(4)             1(90)   1(85)
  der(10;17)         1(85)   \-
  der(15;7)          1(90)   \-
  der(11;10)         1(5)    \-
  der(2;5)           1(5)    \-
  der(17;4)          1(5)    \-
  der(4;22)          \-      1(95)
  der(10)            \-      1(100)
  der(8;17)          \-      2(85)
  der(17)            \-      2(85)
  der(19;17)         \-      1(5)
  der(7)             \-      1(5)

![**Figure 8.** Karyotype arrays of the immortal, tumorigenic clones cen3telS2 PD84 (**A**) and a sub-clone cen3telS2 PD143 (**B**) based on data of [Table 5](#T5){ref-type="table"}. The cen3telS2 PD84 clone arose spontaneously in an independently growing preneoplastic aliquot of the cen3tel mass culture (from which also cen3tel PD166 originated) 84 generations after transfection with overexpressed telomerase. Upon further cultivation for 59 generations, the cen3telS2 PD84 clone was supplanted by a more transformed and faster growing variant, cen3telS2 PD143. Comparative karyotype arrays revealed that PD143 is a near-tetraploid, clonal variant of cene3teS2 PD84 ([Table 5](#T5){ref-type="table"}).](cc-12-783-g8){#F8}

In agreement with the karyotypic individuality of cen3telS2 PD84, the clone differed from cen3tel PD166 in an individual growth rate, which was about two times lower than that of the cen3tel PD166. Moreover, the latent period from the time of transfection of the primary cen3-skin biopsy was much shorter, namely 84 cell generations, compared with the 166 cell generations of the cen3tel PD166 clone.

We infer from available data that the S2 PD84 clone is immortal in terms of the Hayflick definition as follows. In our studies we had passaged the clone for 25 cell generations. In addition, Mondello et al. have tested its stability by demonstrating that the clone is tumorigenic in athymic mice (Mondello, personal communication). Considering that the PD84 stem cell has survived about 30 cell generations to form an experimental tumor of about 1 ml, or 10^9^ cells,[@R5]^,^[@R74] and that the same PD84 clone has also survived 25 generations in our cultures, the PD84 clone has passed the 50 generation-threshold for immortality by the Hayflick limit. The clone is thus probably immortal, much like the PD166 clone derived from the same preneoplastic cen3tel precursor cells.

### Conclusions

\(1\) The origins of two tumorigenic clones, with different individual clonal karyotypes and phenotypes, and different individual latent periods from the same aneuploid non-neoplastic cen3tel mass culture confirm the prediction of the speciation theory that immortality and tumorigenicity are intrinsic elements of clonal and flexible cancer-specific karyotypes

By contrast, the probability that a genetically independent,[@R5]^,^[@R76] but non-essential immortalization event (Introduction and Discussion) would coincide with tumorigenicity by chance is only one in a million, because the rates of mutations in cancer cells are only about 10^−6^.[@R77]^-^[@R79] Compare this to the ubiquity of immortality in cancer. One might argue, however, that cen3tel cells were already immortalized by transfection with overexpressed telomerase. But we have shown in [Figure 4](#F4){ref-type="fig"} that such cells are karyotypically highly unstable and thus not immortal in themselves.

\(2\) The origins of two karyotypically unrelated neoplastic clones from the same population of aneuploid cells supports the prediction of the speciation theory that cancers arise stochastically by independent karyotypic rearrangements. Heng et al. confirm this conclusion: "when performing multiple runs of evolutionary experiments using cell populations derived from the same initial cells, the end results are not the same (individual cancer cells) and thus are not predictable."[@R12]

In the following, we show a new example of karyotypic-phenotypic linkage, namely the evolution of a new, more dominant-neoplastic and immortal subclone from cen3telS2 PD84.

Near-tetraploid tumorigenic subclone overgrows near-diploid precursor cen3telS2 PD84
------------------------------------------------------------------------------------

The speciation theory predicts that owing to the inherent flexibility of cancer karyotypes, cancers can evolve subspecies with enhanced tumorigenicity at high rates compared with mutation.[@R45]^,^[@R80] As a possible example of subspeciation, we have analyzed here a tumorigenic variant of cen3telS2 PD84 that had supplanted this clone 59 generations after its first appearance, at PD143 (Mondello, unpublished). Compared with cen3telS2 PD84, the new neoplastic PD143 variant grew faster, and its cells looked more transformed, i.e., more amorphic and polymorphic than those of its precursor PD84 (not shown).

As a test for a karyotypic basis for this evolution, we compared the karyotype of PD143 to that of its suspected predecessor PD84. It is shown in [Figure 7B](#F7){ref-type="fig"} that the karyotype of the new PD143 was different from, but possibly a polyploid version of, PD84. Following this clue we compared arrays of 20 karyotypes of cen3telS2 PD143 and PD84 side-by-side in [Table 5](#T5){ref-type="table"} and [Figure 8](#F8){ref-type="fig"}. These comparisons indicated that PD143 is a karyotypic duplication of PD84 on the following grounds: (1) PD143 has a clonal, near-tetraploid chromosome number of 85 ± 1, compared with the chromosome number of 46 ± 1 of PD84; (2) The copy numbers of 15 of the 23 intact chromosomes of PD143 are exact duplicates of the copy numbers of the same PD84-chromosomes. The remaining eight intact PD84-chromosomes were either not amplified or amplified 1.5- or 3-fold in PD143; (3) Both tumorigenic clones share one specific marker chromosome, der4. Further, the early presence of three near-tetraploids in the karyotype array of cen3tel PD84 ([Fig. 8A](#F8){ref-type="fig"}) already indicated the proclivity of PD84 for tetraploidization, which eventually generated PD143.

We deduce (1) from the high, 80--100% clonality of the chromosome copy numbers of cen3telS2 PD143, which is a proxy for stability ([Table 5](#T5){ref-type="table"} and [Fig. 8](#F8){ref-type="fig"}), and (2) from the immortality of its precursor that cen3tel PD143 has inherited karyotypic immortality from its precursor PD84.

### Conclusions

\(1\) The duplication of the gene dosages of the cen3telS2 PD84 in the subspecies PD143 by polyploidization explains the enhanced tumorigenicity of cen3telS2 PD143 compared with PD84. It thus also explains its ability to supplant the whole PD84 culture within 20 to 40 generations ([Figs. 8](#F8){ref-type="fig"} and [11](#F11){ref-type="fig"}). Further the co-segregation of tumorigenicity and immortality over 59 unselected generations and during a major karyotypic remodeling lends new support to our theory that these characters are karyotypically linked.

\(2\) Since all six immortal and tumorigenic clones and subclones studied so far originated from cells transfected with overexpressed telomerase, it could be argued that clonal and flexible karyotypes were not sufficient to immortalize these clones, and hence also depend on telomerase for immortalization. In the next and last experiment we have addressed this question.

SV40 tumor virus induces immortal neoplastic clones with flexible karyotypes in cells of a telomerase-deficient mouse
---------------------------------------------------------------------------------------------------------------------

To determine whether either endogenous or exogenous telomerase is necessary for immortalization, we asked whether SV40 tumor virus generates immortal neoplastic clones in cells of a telomerase-deficient mouse. The study of Argilla et al. with telomerase-deficient mice, introduced above, already suggested that neoplastic transformation is telomerase-independent, but did not identify a mechanism of immortalization[@R46] (Introduction).

In view of this, we analyzed the karyotypes of foci of SV40-transformed lung and tail cells from a telomerase-deficient mouse for clonal and flexible, cancer-specific karyotypes. Such foci were obtained 2 to 3 mo after infection of primary cell cultures ("Materials and Methods"). Individual karyotypes of a lung cell focus, termed FL1 and of a tail cell focus, termed FT1, are shown in [Figure 9](#F9){ref-type="fig"}, and arrays of 20 karyotypes are shown in [Figure 10](#F10){ref-type="fig"} and [Table 6](#T6){ref-type="table"}.

![**Figure 9.** Karyotypes of immortal clones of SV40 virus-transformed lung cells, FL1 (**A**) and tail cells, FT1 (**B**) from a telomerase-deficient mouse (see also [Table 6](#T6){ref-type="table"}). The transformed clones arose together with their new individual karyotypes 2--3 mo after infection of the cells with SV40 virus.](cc-12-783-g9){#F9}

![**Figure 10.** Karyotype arrays of immortal, neoplastic clones of SV40 virus-transformed lung cells, FL1 (**A and B**) and tail cells, FT1 (**C**) from a telomerase-deficient mouse. The clones appeared 3 mo after infection by SV40 tumor virus together with their new clonal and flexible karyotypes. Karyotype arrays of the lung-derived focal culture, FL1 were determined 35 and 65 generations after isolation of the focal culture. The arrays show that the FL1 karyotype was near-triploid with near clonal FL1-specific chromosome numbers and chromosome copy numbers (see also [Table 6](#T6){ref-type="table"}). The karyotype array of the tail-derived focal culture, FT1 was determined 25 generations after isolation of the focal FT1 clone. The array shows that the FT1 karyotype was hypo-diploid with 94--100% clonal chromosome numbers and chromosome copy numbers.](cc-12-783-g10){#F10}

###### **Table 6.** Chromosome numbers and copy numbers of two immortal SV40-transformed clones of telomerase-deficient mouse cells, FL1 and FT1

  Neoplastic clones   FT1 PD25       FL1 PD35       FL1 PD65
  ------------------- -------------- -------------- ---------------------
  1                   2(100)         3(100)         3(80)
  2                   2(100)         3(85)          3(95)
  3                   2(100)         2(75)          3(85)
  4                   2(100)         1(95)          1(95)
  5                   2(100)         4(85)          2(35), 3(40), 4(20)
  6                   2(100)         2(60), 3(30)   1(55), 2(45)
  7                   2(100)         3(70)          3(95)
  8                   2(100)         3(35), 4(50)   3(50), 4(40)
  9                   2(100)         3(70)          3(85)
  10                  2(94)          3(35), 4(60)   4(80)
  11                  2(100)         4(85)          4(60)
  12                  1(100)         2(95)          2(85)
  13                  2(94)          2(100)         2(90)
  14                  1(100)         4(85)          2(80)
  15                  2(94)          3(65)          3(30), 4(45)
  16                  2(100)         3(85)          2(80)
  17                  2(100)         3(80)          1(65)
  18                  2(100)         3(75)          2(70)
  19                  2(100)         3(35), 4(55)   3(45), 4(15)
  X                   1(100)         2(100)         2(70)
  Y                   1(69), 2(31)   0              0
  der(4) long         \-             1(95)          1(85)
  der(4;12)           \-             1(90)          1(95)
  der(6;3;19)         \-             1(65)          1(70)
  der(13;15)          \-             1(100)         1(75)
  i(17)               \-             \-             1(55)
  der(16;19)          \-             \-             1(55)
  i(6)                \-             \-             1(35)
  der(18;19)          \-             \-             1(35)
  der(5;14)           \-             \-             1(25)

These data indicate that FL1 has a near triploid karyotype with clonal chromosome numbers of 59 ± 3 (compared with the 40 chromosomes a normal mouse). The copy numbers of 16 intact and four FL1-specific marker chromosomes were 65 to 100% clonal and thus stable during 35 and 65 cell generations ([Fig. 10](#F10){ref-type="fig"} and [Table 6](#T6){ref-type="table"}). The copy numbers of the remaining four intact chromosomes oscillated between two or three complementary percentages with high clonality ([Table 6](#T6){ref-type="table"}).

In agreement with the theory that cancer karyotypes are clonal but variable within clonal margins, the FL1 clone included minor fractions (0--35%) of chromosomes with near-clonal copy numbers that oscillated ± 1 around clonal values. In addition the clone had evolved five new, marker chromosomes at intermediate degrees of clonalities (25--55%) between generations PD35 to PD65 ([Table 6](#T6){ref-type="table"}).

Since the percentages of chromosomal clonalities and near-clonalities of the FL1 clone were stable for over 65 generations (except for some new subclonal marker chromosomes), we concluded that the FL1 clone is immortal based of the Hayflick definition. In the meantime, we have found that the clone was stable for another 25 generations, for a total of 90 generations in culture, but a new karyotype analysis has not been performed.

The tail-derived FT1 clone was hypo-diploid with a clonal chromosome number of 38 ± 1 ([Figs. 9](#F9){ref-type="fig"} and [10](#F10){ref-type="fig"} and [Table 6](#T6){ref-type="table"}). The clonality of the chromosome copy numbers of FT1 at generation PD25 was very high, ranging between 94 and 100%. Thus FT1 was highly stable and is therefore likely to be immortal, although it has not yet been passaged and karyotyped for 50 generations.

We suggest that two factors explain the relatively high flexibility of FL1 compared with that of FT1: (1) the karyotype-destabilizing function of the high, near-triploid aneuploidy of FL1; and probably (2) the ongoing aneuploidizing function of the SV40 T-antigen, knowing that the dosage and activity of the T-antigen of SV40-virus can be very high in some cells.[@R38]^,^[@R68]^,^[@R81]^-^[@R83]

### Conclusions

\(1\) Since both SV40-induced neoplastic clones of cells from a telomerase-deficient mouse were immortal and carried clonal and flexible karyotypes, and since the new clones and their new clonal karyotypes both appeared late after infection with SV40 virus, we conclude that these new clonal and flexible karyotypes were sufficient to transform and immortalize cells of telomerase-free mice.

\(2\) Further, we conclude that the role of the SV40-T-antigen in this immortalization experiment was to initiate the evolution of these new karyotypes by inducing random aneuploidy.[@R38]^,^[@R68]^,^[@R81]^-^[@R83] Thus SV40 T-antigen and overexpressed telomerase play the same indirect role in immortalization and neoplastic transformation, namely the induction of random aneuploidy (Results, "How does overexpressed telomerase induce..." and [Fig. 4](#F4){ref-type="fig"}).

Discussion
==========

Karyotypic theory of immortality
--------------------------------

With the longitudinal analyses of cells transfected with overexpressed telomerase or infected with SV40-virus, we have now before us a complete sequence of the karyotypic stages that generate cancer and immortality. [Figure 11](#F11){ref-type="fig"} diagrams these karyotypic stages during carcinogenesis of a virtual organ of 10^6^ cells: (1) the induction of random aneuploidy in an arbitrary 1% of normal cells by a carcinogen, such as overexpressed telomerase ([Fig. 4](#F4){ref-type="fig"}) or SV40 virus T-antigen ([Figs. 9](#F9){ref-type="fig"} and [10](#F10){ref-type="fig"}); (2) self-catalyzed progression of random aneuploidy over many cell generations reaching up to 100% of the initiated cell population; the aneuploid human skin cells shown in [Figure 4](#F4){ref-type="fig"}, 37 and 100 generations after transfection with overexpressed telomerase are examples; (3) the stochastic evolution of an autonomous cancer stem cell with a new, clonal flexible karyotype and phenotype; this new autonomous cancer cell supplants the 10^6^ non-cancerous precursors in our virtual organ of 10^6^ cells within 20 generations after its origin ([Figs. 5](#F5){ref-type="fig"} and [8](#F8){ref-type="fig"}); (4) self-catalyzed karyotypic variations of cancer cells generate new unselected subspecies, spontaneously ([Fig. 5](#F5){ref-type="fig"}), and drug-resistant or metastatic subspecies, selectively.[@R84]^,^[@R85]

This sequence of events explains why in our experiments immortality and tumorigenicity: (1) correlated exactly with cancer-specific clonal and flexible karyotypes; (2) originated simultaneously with such karyotypes; and (3) progressed with subspecies of these karyotypes. Therefore, we conclude that clonal and flexible cancer karyotypes generate immortality and tumorigenicity simultaneously and independent of telomerase.

1.  The literature supports this view on several grounds:

    1.  According to the "Mitelman Database of Chromosome Aberrations in Cancers," an exact and huge correlation exists between immortality and individual, clonal yet flexible cancer karyotypes---namely over 61,000 cases![@R86]

    2.  Levan and Biesele adduced independent evidence for the simultaneous origins of immortality and tumorigenicity in 1958: "One especially interesting change, demonstrated often to coincide with the establishment of the capacity for indeterminate growth in vitro, is the acquirement of malignant properties, made evident on inoculation of the cell strain in vivo."[@R63]. Others have since described exact correlations between "indeterminate growth" in vitro and tumorigenicity.[@R87]

    3.  Several previous studies observed that immortalization and neoplastic transformation are independent of telomerase-function: (a) Mondello et al. observed that the immortalization the cen3tel PD166 clone described above coincided with the loss, instead of an expected gain of telomere length. The telomeres of cen3tel PD166 were "decreased and stabilized around values lower than those observed in senescent cen3 cells (at) 6 kb" during immortalization. By contrast, the telomeres of mortal cen3 precursor cells measured 8.5 kb;[@R32] (b) Another study found that the lengths of telomeres are reduced in 40% of all tumors compared with the normal tissue of origin;[@R88] (c) Others wrote, in agreement with Holliday,[@R89] that "Approximately a quarter of in vitro immortalized cell lines so far examined have no detectable telomerase activity, yet have very long and heterogeneous telomeres"[@R90].

In sum, the literature supports the theory that immortality is an integral part of the cancer karyotype, and is independent of telomerase.

Why are cancers immortal?
-------------------------

Current cancer researchers and biology textbooks faithfully report that immortality is one of the "hallmarks of cancer"[@R5]^,^[@R8]^,^[@R9]^,^[@R29]^,^[@R76]. There is, however, no compelling information on why cancers are immortal. According to cancer researcher Blagosklonny, immortality is in fact a "paradox," because "it brings no immediate replicative advantage."[@R6].

The customary answer to the immortality question suggests that immortality is necessary for cancer cells to grow from single stem cells to the numbers of cells that generate fatal cancers.[@R5] Since fatal cancers consist of 1 to 1,000 ml tissue or 10^9^ to 10^12^ cells,[@R5]^,^[@R91] about 30 to 40 cell generations are necessary to generate such cancers from a single cancer stem cell (2^30^ = 10^9^ and 2^40^ = 10^12^).

But, according to the Hayfilck limit the reproductive capacity of somatic cells is 50 generations, enough to generate 2^50^ or 10^15^ cells, the equivalent of 10 human bodies.[@R5]^,^[@R92] As shown in this study and others cited above the reproductive capacity of human cells even from centenarians can actually be over 100 generations. There is also no consistent evidence that somatic cells must be \"immortalized\" by activated telomerase to produce sufficient numbers of cells for fatal cancers. For example, we found here that somatic cells of telomerase-deficient mice become immortal cancer cells without any telomerase. Moreover several studies have found normal telomere lengths in somatic human cells after a normal lifetime, even of 100 y.[@R93]^-^[@R96] Such cells would also not depend on \"immortalization\" by activated telomerase to produce sufficient numbers of cells for carcinogenesis. So why are all cancers immortal, if immortality is not necessary to produce sufficient numbers of cells for fatal cancers?

Only the speciation theory of cancer offers a consistent explanation for the characteristic immortality of cancer cells: since cancers are indeed autonomous species of their own, they need a stable and, thus, immortal karyotype like all other species[@R50]^-^[@R55]---the price "for crossing the threshold of autonomy," as Huxley pointed out in 1956.[@R1] The dynamic equilibrium between inherent karyotypic variation and selection for cancer-specific autonomy advanced here is a stable yet flexible mechanism that satisfies this requirement.[@R11]^-^[@R13] The same mechanism would also explain how cancers escape Muller's ratchet.

This view confirms and explains Blagosklonny's proposal that immortality must be "a byproduct of something that brings about an immediate replicative advantage"[@R6]---namely cancer-specific reproductive autonomy.

Flexibility of cancer karyotypes generating drug-resistance and metastasis at high rates
----------------------------------------------------------------------------------------

Immortality is just one of several consequences of the inherent karyotypic flexibility of cancer karyotypes. The karyotypic flexibility of cancers also explains the spontaneous karyotypic variations that generate subspecies that are drug-resistant[@R80]^,^[@R85] or metastatic[@R84]---at rates of 10^−1^ to 10^−5^.[@R80]^,^[@R84]^,^[@R85]^,^[@R97]^,^[@R98] These rates far exceed those of conventional gene mutations, which occur in cancer cells only at rates of 10^−6^ per dominant and 10^−12^ per recessive gene per mitosis.[@R77]^-^[@R79] Thus the high, cancer-specific rates of phenotypic variations, to metastasis or drug-resistance, are consequences of inherently flexible cancer karyotypes, rather than of gene mutations.

The karyotypic variations that keep cancers immortal over thousands of cell generations[@R11] also depend on these high rates of variation in order to exceed the rates of conventional lethal mutations of Muller's ratchet.

In sum, the inherent karyotypic flexibility of cancer is the basis for its existence, considering that it originates with an unstable karyotype, and it is the common cause of its most notorious, if gratuitous acquisitions: drug-resistance and metastasis. In the words of cancer researcher and physician Mark Vincent, "Thus is constructed a machine in which the associated DNA instability is not just a pointless collection of errors, but in fact the principal means to the goal of cellular survival."[@R13].

Materials and Methods
=====================

Cells and cell culture
----------------------

The immortal, tumorigenic human cell lines, HA1, HA1--2 and BJ, prepared as described previously,[@R29] were kindly provided by Robert Weinberg (Massachusetts Institute of Technology). Chiara Mondello (Istituto di Genetica Molecolare, University of Pavia) kindly provided the cen3tel cultures of primary skin cells at various generations after transfection with artificially overexpressed telomerase analyzed here. The primary cen3-cells had been derived from a human centenarian, as described previously.[@R32]^,^[@R40] The cultures studied are labeled following the generations or population doublings (PD) after transfection of the primary culture with overexpressed telomerase, namely PD37, PD100, PD166, PD617, PD1014 and cen3telS2 PD84 and PD143.

Primary lung and tail cultures were prepared from a young telomerase-minus mouse, strain B6.Cg-Terc, from the Jackson Laboratory, Bar Harbor, ME. For this purpose the lung and tail of the mouse were excised shortly after it was killed with CO~2~. The tissues were then minced with razor blades, washed free of blood cells and debris and then incubated in serum-free medium containing about 0.5% trypsin at 37°C on a shaker for 15 to 30 min. We monitored the dissociation of tissue nuggets into single cells by checking aliquots of the trypsin-digest under the microscope. Cells were then incubated in culture medium RPM1640 supplemented with 5% fetal calf serum to which 0.1 to 0.5 mg/ml collagenase (Sigma) was added to dissociate trypsin resistant cell nuggets for several up to 24 h, depending on the degree of dissociation. SV40 was kindly provided by Michele Carbone (Cancer Research Center of Hawaii, University of Hawaii) or purchased from the American Type Culture Collection. The mouse cell cultures were then infected with SV40 virus and incubated 2--3 mo until foci of transformed cells were observed, as described previously.[@R45]

Karyotyping human and mouse cells
---------------------------------

One to 2 days before karyotyping, cells were seeded at about 50% confluence in 3 ml RPMI 1640 medium containing 5% fetal calf serum in a 5-cm culture dish. After reaching \~75% confluence, Colcemid (KaryoMax Colcemid solution; Gibco Invitrogen) was added to 50 ng per ml medium. The culture was then incubated at 37°C for 4--12 h. Subsequently, cells were dissociated with trypsin, washed in 3 ml of physiological saline (depending on purity) and incubated in 0.075 molar KCl at 37°C for 15 min. Subsequently the solution was cooled in ice-water mixed with 0.1 volume of freshly mixed glacial acetic acid-methanol (1:3, vol. per vol.) and centrifuged at 800 g. The cell pellet was then gradually suspended in the methanol-acetic a solution and incubated at room temperature for 15 min. The cells were then pipetted onto a microscope slide to give a suitable density of metaphases for microscopic analysis. If necessary, residual cellular debris was removed by resuspending the cells again in methanol-acetic acid and recentrifuging at 800 g. Slides with suitable metaphase chromosomes were hybridized with chromosome-specific, color-coded DNA probes (MetaSystems) as described by the manufacturer and by us previously.[@R45]^,^[@R84]
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